Abbott Delivers Industry-Leading Performance for 2011
January 2012
Abbott delivered its fifth consecutive year of double-digit ongoing earnings per share (EPS) growth with sales increasing more than 10 percent to $38.9 billion in 2011 driven by strong performance across its diverse businesses, particularly in emerging markets. Abbott also continued to advance its late-stage pipeline, made great strides to improve the overall efficiency of the company in 2011 and generated record cash flow of more than $9 billion.
Abbott's fourth-quarter 2011 EPS (excluding items) increased more than 11 percent to $1.45, exceeding analysts' expectations. Sales increased more than 4 percent (including exchange) in the quarter to $10.4 billion, including sales of $2.5 billion in emerging markets (nearly 25 percent of global sales).
Abbott also issued its ongoing EPS guidance for 2012 of $4.95-$5.05, reflecting another year of strong performance.
- For complete details, including business highlights for the quarter, see our earnings release.
